Glaucoma 360 New Horizons Forum
Glaucoma 360 New Horizons Forum
February 13, 2020
1 min watch
Save

VIDEO: Aerie to test Rho kinase inhibitor implant for glaucoma

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

SAN FRANCISCO — At the Glaucoma 360: New Horizons Forum, Casey C. Kopczynski, PhD, chief scientific officer and co-founder of Aerie Pharmaceuticals, explains the company’s plan to test its AR-13503 sustained-release Rho kinase inhibitor implant for the treatment of glaucoma.